Bio

Casey Gordon has been part of Northgate since 2016 as a member of the firms Operating Committee, with a key role supporting Northgate’s business development and global marketing programs. Mr. Gordon serves as the Managing Partner of Northgate. Mr. Gordon is also the Head of Private Investments at The Capital Partnership (“TCP”) Group of Companies where he has worked since 2006. He is responsible for private equity investments and new business development, including work on corporate initiatives like the acquisition and oversight of Northgate Capital. Mr. Gordon has led investments for TCP across a number of sectors including financial services, healthcare and technology. Mr. Gordon is also currently a member of the Board of Directors for TCP portfolio companies, Atia Vision and Supira Medical. Previously, he was a member of the Board of Directors for NuVera Medical until December 2020 when NuVera was sold to Ethicon, a wholly-owned subsidiary of Johnson & Johnson. Mr. Gordon holds a BA in Sociology from Johns Hopkins University and an MBA from the MIT Sloan School of Management.